A case of hyperthyroidy developing in "pegylated-interferon" therapy.
Aslan
Mehmet
M
Department of Gastroenterology, Faculty of Medicine, Harran University, Bahcelievler Mah. Sema Apt. A Blok No. 8, Sanliurfa, 63200, Turkey. m.aslan301@mynet.com
Nazligul
Yasar
Y
Aksoy
Nurten
N
Yilmaz
Nevin
N
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D016903:Drug Monitoring / Q000379:methods; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D013960:Thyroid Function Tests
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b